EMEIS Fundamental Analysis - EMEIS SA

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to EMEIS. EMEIS was compared to 28 industry peers in the Health Care Providers & Services industry. EMEIS may be in some trouble as it scores bad on both profitability and health. EMEIS is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

EMEIS had negative earnings in the past year.

EMEIS had a positive operating cash flow in the past year.

In multiple years EMEIS reported negative net income over the last 5 years.

In the past 5 years EMEIS always reported a positive cash flow from operatings.

1.2 Ratios

EMEIS has a worse Return On Assets (-3.07%) than 89.29% of its industry peers.

With a Return On Equity value of -23.89%, EMEIS is not doing good in the industry: 89.29% of the companies in the same industry are doing better.

Looking at the Return On Invested Capital, with a value of 0.03%, EMEIS is doing worse than 85.71% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-3.07%
ROE	-23.89%
ROIC	0.03%

ROA(3y)-7.04%

ROA(5y)-3.96%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

EMEIS's Operating Margin of 0.08% is on the low side compared to the rest of the industry. EMEIS is outperformed by 85.71% of its industry peers.

EMEIS's Operating Margin has declined in the last couple of years.

EMEIS does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	0.08%
PM (TTM)	N/A
GM	N/A

OM growth 3Y-79.31%

OM growth 5Y-64.56%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EMEIS is destroying value.

Compared to 1 year ago, EMEIS has more shares outstanding

Compared to 5 years ago, EMEIS has less shares outstanding

The debt/assets ratio for EMEIS is higher compared to a year ago.

2.2 Solvency

EMEIS has an Altman-Z score of 0.60. This is a bad value and indicates that EMEIS is not financially healthy and even has some risk of bankruptcy.

The Altman-Z score of EMEIS (0.60) is worse than 75.00% of its industry peers.

The Debt to FCF ratio of EMEIS is 51.23, which is on the high side as it means it would take EMEIS, 51.23 years of fcf income to pay off all of its debts.

Looking at the Debt to FCF ratio, with a value of 51.23, EMEIS is doing worse than 82.14% of the companies in the same industry.

A Debt/Equity ratio of 4.80 is on the high side and indicates that EMEIS has dependencies on debt financing.

EMEIS has a Debt to Equity ratio of 4.80. This is amonst the worse of the industry: EMEIS underperforms 85.71% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	4.8
Debt/FCF	51.23
Altman-Z	0.6

ROIC/WACC0.01

WACC4.48%

2.3 Liquidity

A Current Ratio of 0.62 indicates that EMEIS may have some problems paying its short term obligations.

The Current ratio of EMEIS (0.62) is worse than 78.57% of its industry peers.

EMEIS has a Quick Ratio of 0.62. This is a bad value and indicates that EMEIS is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of EMEIS (0.62) is worse than 71.43% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.62
Quick Ratio	0.62

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

EMEIS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -142.36%.

Looking at the last year, EMEIS shows a quite strong growth in Revenue. The Revenue has grown by 8.43% in the last year.

The Revenue has been growing by 8.55% on average over the past years. This is quite good.

EPS 1Y (TTM)-142.36%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-114.25%

Revenue 1Y (TTM)8.43%

Revenue growth 3Y9.45%

Revenue growth 5Y8.55%

Sales Q2Q%7.73%

3.2 Future

EMEIS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.92% yearly.

The Revenue is expected to grow by 2.70% on average over the next years.

EPS Next Y24.08%

EPS Next 2Y24.28%

EPS Next 3Y21.78%

EPS Next 5Y17.92%

Revenue Next Year4.75%

Revenue Next 2Y4.73%

Revenue Next 3Y4.79%

Revenue Next 5Y2.7%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EMEIS. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EMEIS. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of EMEIS indicates a somewhat cheap valuation: EMEIS is cheaper than 71.43% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	10.22
EV/EBITDA	N/A

4.3 Compensation for Growth

EMEIS's earnings are expected to grow with 21.78% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y24.28%

EPS Next 3Y21.78%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

EMEIS does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

EMEIS SA

EPA:EMEIS (9/5/2025, 5:29:45 PM)

11.04

-0.13 (-1.16%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)05-13 2025-05-13

Earnings (Next)09-29 2025-09-29

Inst Owners55.54%

Inst Owner ChangeN/A

Ins Owners0%

Ins Owner ChangeN/A

Market Cap1.78B

Analysts75.38

Price Target12.34 (11.78%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)2.25%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)-98.8%

EPS NY rev (3m)-98.8%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)-0.51%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.32
P/FCF	10.22
P/OCF	3.78
P/B	1.03
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-2.65

EYN/A

EPS(NY)-1.7

Fwd EYN/A

FCF(TTM)1.08

FCFY9.79%

OCF(TTM)2.92

OCFY26.49%

SpS34.91

BVpS10.68

TBVpS-7.69

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-3.07%
ROE	-23.89%
ROCE	0.04%
ROIC	0.03%
ROICexc	0.03%
ROICexgc	0.04%
OM	0.08%
PM (TTM)	N/A
GM	N/A
FCFM	3.1%

ROA(3y)-7.04%

ROA(5y)-3.96%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3Y-77.23%

ROICexcg growth 5Y-61.49%

ROICexc growth 3Y-76.08%

ROICexc growth 5Y-60.94%

OM growth 3Y-79.31%

OM growth 5Y-64.56%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.42

Health

		Industry Rank	Sector Rank
Debt/Equity	4.8
Debt/FCF	51.23
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	5.28%
Interest Coverage	250
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.62
Quick Ratio	0.62
Altman-Z	0.6

F-Score4

WACC4.48%

ROIC/WACC0.01

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)5.82%

Cap/Sales(5y)13.23%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-142.36%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-114.25%

EPS Next Y24.08%

EPS Next 2Y24.28%

EPS Next 3Y21.78%

EPS Next 5Y17.92%

Revenue 1Y (TTM)8.43%

Revenue growth 3Y9.45%

Revenue growth 5Y8.55%

Sales Q2Q%7.73%

Revenue Next Year4.75%

Revenue Next 2Y4.73%

Revenue Next 3Y4.79%

Revenue Next 5Y2.7%

EBIT growth 1Y103.51%

EBIT growth 3Y-77.35%

EBIT growth 5Y-61.53%

EBIT Next Year10863.7%

EBIT Next 3Y422.27%

EBIT Next 5Y253.39%

FCF growth 1Y293.3%

FCF growth 3YN/A

FCF growth 5Y14.58%

OCF growth 1Y28.92%

OCF growth 3Y-14.44%

OCF growth 5Y-10.16%

EMEIS SA (EMEIS.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens